AXGN
Axogen, Inc. Common Stock
stockNASDAQ
it's time to rethink nerve repair! axogen (nasdaq: axgn) is a medical products company with a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration. people suffer traumatic injuries or undergo surgeries that impact the function of their peripheral nerves daily. damage may cause loss of function and feeling. axogen is bringing the science of nerve repair to life with its avance® nerve graft which axogen believes is the first and only commercially available allograft for bridging nerve discontinuities, axoguard® nerve connector, a coaptation aid allowing for close approximation of severed nerves, and axoguard® nerve protector that protects nerves during the healing process.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 36.48 | 2026-10-21 | +30.93% | -1.319 |
| 1M | 43.36 | 2026-09-28 | +10.16% | -0.157 |
| 3M | 41.15 | 2026-07-28 | +16.07% | 0.980 |
| 6M | 41.99 | 2026-04-28 | +13.75% | 0.598 |
| 1Y | 18.08 | 2025-10-28 | +164.19% | 0.841 |
| 2Y | 13.94 | 2024-10-28 | +242.65% | — |
| 5Y | 15.13 | 2021-10-28 | +215.70% | 1.150 |
Axogen, Inc. Common Stock (NASDAQ:AXGN) stock price today is $47.77, and today's volume is 5,227,121. AXGN is up 27.509% today. The 30 day average volume is 1.41M. AXGN market cap is $2.80B with 58.67M shares outstanding.